About Clianslabs
Clianslabs is a company based in Hyderabad (India) founded in 2018. It operates as a B2B. The company has 83 employees as of March 31, 2023. Clianslabs offers products and services including Clinical Research Services, Bioanalytical Infrastructure, and IT Infrastructure. Clianslabs operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Hyderabad, India
- Employees 83 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Clians Labs Private Limited
- Date of Incorporation 23 May, 2017
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.13 M (USD)15.37as on Mar 31, 2023
-
Net Profit
$650.75 K (USD)-17.5as on Mar 31, 2023
-
EBITDA
$1.93 M (USD)4.39as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
83
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clianslabs
Clianslabs offers a comprehensive portfolio of products and services, including Clinical Research Services, Bioanalytical Infrastructure, and IT Infrastructure.
Delivers clinical research solutions for clients
Provides bioanalytical facilities and equipment
Offers IT systems for research operations
Funding Insights of Clianslabs
Investments & Acquisitions by Clianslabs
Financial Statements - Clianslabs
Clianslabs Comparisons
Competitors of Clianslabs
Clianslabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Latest news on Clianslabs
Frequently Asked Questions about Clianslabs
Clianslabs was founded in 2018.
Clianslabs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Clianslabs is 83.
Annual revenue of Clianslabs is $5.13M as on Mar 31, 2023.
Clians Labs Private Limited is a clinical research organization based in Hyderabad, India, offering a wide range of services including clinical research, bioanalytical, and IT infrastructure. They maintain stringent quality systems with an independent QA team and state-of-the-art facilities spanning over 61,027.5 square feet. The company serves clients through reliable, objective solutions, utilizing sophisticated equipment and compliant software for research activities.
Clianslabs's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Clianslabs offers Clinical Research Services, Bioanalytical Infrastructure, and IT Infrastructure.